Titre:
  • Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease.
Auteur:Allanore, Yannick; Khanna, Dinesh; Smith, Vanessa; Bondue, Benjamin; Hoffmann-Vold, Anna-Maria; Kuwana, Masataka; Merkel, Peter PA; Stock, Christian; Sambevski, Steven; Denton, Christopher Paul C.; SENSCIS Trial Investigators, Benjamin Bondue
Informations sur la publication:Rheumatology, 63, 3, page (639-647)
Statut de publication:Publié, 2024-03-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:antifibrotic agents
pulmonary fibrosis
pulmonary function tests
scleroderma
systemic
MeSH keywords:Humans
Lung Diseases, Interstitial -- drug therapy -- etiology
Pulmonary Fibrosis
Indoles -- therapeutic use
Scleroderma, Systemic -- complications -- drug therapy
Langue:Anglais
Identificateurs:urn:issn:1462-0324
info:doi/10.1093/rheumatology/kead280
info:pii/7193095
info:pmid/37294870
PMC10907814